multivalent DNA vaccine (Cyto Pulse/Karolinska Institute/Swedish Institute for Infectious Disease Control)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namemultivalent DNA vaccine (Cyto Pulse/Karolinska Institute/Swedish Institute for Infectious Disease Control)
Drug Alias Namemultivalent DNA vaccine (Cyto Pulse/Karolinska Institute/SIIDC)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenTanzaniaFrance
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKarolinska Institutet
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCellectis SaKarolinska InstitutetCyto Pulse Sciences Inc +[4] 
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A